Biotechnology
31 results total, viewing 11 - 20
Alexion Pharmaceuticals Inc. has made a $25 million preferred equity investment in Moderna Therapeutics and will also provide $100 million up front as part of a long-term agreement to develop treatments for rare diseases with Moderna’s messenger RNA Therapeutics platform, the two companies announced Monday. more
Tech Collective, Rhode Island’s bioscience and information technology industry association will host a Bioscience Industry Skills Gap Forum on Wednesday, March 26 from 8:30 to … more
Global biotech firm Covidien PLC has acquired Israeli medical tech company Given Imaging Ltd. for $860 million, a move that will allow Covidien to expand into the multibillion dollar gastrointestinal product market. The acquisition is expected to add between $40 and $50 million in quarterly revenue for Covidien. more
Dr. Anne S. De Groot, EpiVax CEO and University of Rhode Island professor, has been named one of the most influential people in the vaccine industry by the national vaccine industry organization VaccineNation. more
The second annual SkillsUSA Rhode Island student bioscience competition on March 8 drew 36 students from Coventry High School, Warwick Veterans Memorial High School, Davies Career and Technical High School, and the Woonsocket Career and Technical Center. more
Nearly halfway through fiscal year 2014, National Institutes of Health grants to Rhode Island institutions are well short of the pace set in the previous year, according to figures on the NIH’s website. more
MedMates grew up out of a simple premise: Put enough health-tech industry members in a room together, and innovation will take care of itself. more
Medical robotics company Medrobotics Corp. announced the appointment on March 17 of Russell M. Singleton as the company’s senior vice president of research and development. more
NsGene Inc.’s innovative brain-repair therapy couldn’t have come at a better time, as one of the neurodegenerative diseases it would treat – Parkinson’s disease – has gotten a lot of press lately. more
Global biotech firm Covidien PLC reported Friday that its net income rose five-tenths of a percent in its fiscal second quarter, totaling $441 million, or 97 cents per diluted share, compared with $439 million, or 92 cents per diluted share, during the same period a year earlier. more
« Prev | 1 | 2 | 3 | 4 Next »
Calendar
PBN Hosted
Events

Applications are now being accepted for the 14th Annual Business Excellence Awards Program. Deadline to apply is October 1st. And save the date for the Awards Dinner - November 12th at the Providence Marriott.
Advertisement
Purchase Data
Book of Lists
Lists
Book of Lists cover
PBN's annual Book of Lists has been an essential resource for the local business community for almost 30 years. The Book of Lists features a wealth of company rankings from a variety of fields and industries, including banking, health care, real estate, law, hospitality, education, not-for-profits, technology and many more.
Data icons
Data can be purchased as single lists, in either Excel or PDF format; the entire database of the published book, in Excel format; or a printed copy of the Book of Lists.
  • Purchase an e-File of a single list
  •  
  • Purchase an e-File of the entire Book of Lists database
  •  
  • Purchase a printed copy of the Book of Lists
  •  
    National
    Local
    Latest News
    Advertisement